IRIS
BOLLINI, SVEVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.627
AS - Asia 24
SA - Sud America 15
NA - Nord America 2
Totale 6.668
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.624
BR - Brasile 14
CN - Cina 12
VN - Vietnam 5
ID - Indonesia 2
RU - Federazione Russa 2
SG - Singapore 2
US - Stati Uniti d'America 2
AR - Argentina 1
BD - Bangladesh 1
HK - Hong Kong 1
LB - Libano 1
UA - Ucraina 1
Totale 6.668
Salva come PNG Salva come JPEG
Città #
Genova 3.628
Genoa 1.954
Vado Ligure 571
Rapallo 455
Bordighera 10
Beijing 8
Ho Chi Minh City 5
Milan 3
Ashburn 2
Rome 2
Singapore 2
Argudan 1
Beirut 1
Betim 1
Blagoveshchensk 1
Comodoro Rivadavia 1
Divinópolis 1
Duque de Caxias 1
Gramado 1
Guarabira 1
Guarujá 1
Hong Kong 1
Itajaí 1
Jakarta 1
Lavras 1
Oriximiná Municipality 1
Paulínia 1
Pesaro 1
Santana do Ipanema 1
São João da Boa Vista 1
São Paulo 1
Uruçuí 1
Zolochiv 1
Totale 6.662
Salva come PNG Salva come JPEG
Nome #
Beyond cardiomyocyte loss: Role of Notch in cardiac aging 207
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 195
Cardiac lymphatics are heterogeneous in origin and respond to injury 187
First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential 163
Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart 160
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 154
Fetal and perinatal stem cells in cardiac regeneration: Moving forward to the paracrine era 154
Cardiac restoration stemming from the placenta tree: Insights from fetal and perinatal cell biology 154
BRG1-SWI/SNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease 147
The Regenerative Role of the Fetal and Adult Stem Cell Secretome 146
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. 144
Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. 139
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome 136
Supporting data on in vitro cardioprotective and proliferative paracrine effects by the human amniotic fluid stem cell secretome 134
Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. 133
Learning from Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal Large Tissue Defects 131
De novo cardiomyocytes from within the activated adult heart after injury. 130
Amniotic Fluid Stem Cells for Cardiac Regeneration 128
Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses. 126
Triggering Endogenous Cardiac Repair and Regeneration via Extracellular Vesicle-Mediated Communication 124
Resident cardiac progenitor cells: At the heart of regeneration 123
Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation 122
In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. 121
Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications 117
The human amniotic fluid stem cell secretome as new paracrine source to unlock endogenous cardiac regeneration 117
The Amniotic Fluid Stem Cell Secretome: At the Heart of Repair and Regeneration 114
Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts. 112
Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate. 110
Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. 108
Comprehensive profiling of secretome formulations from fetal-and perinatal human amniotic fluid stem cells 108
Dynamic haematopoietic cell contribution to the developing and adult epicardium. 107
Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart. 107
P108The human amniotic fluid stem cell secretome as new promising tool to restore cardiac regeneration by paracrine therapy 106
Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing. 105
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 104
Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy. 100
The regenerative potential of the amniotic fluid stem cell microvesicles 98
Young@Heart: empowering the next generation of cardiovascular researchers 98
Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. 96
'Veni, Vidi, Vici': how to arm your troops in the battlefield of cardiac repair 95
One step closer to finding the Fountain of Youth in our muscles: can we grow old while staying young at heart? 95
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 90
Human Bone Marrow-Derived CD133+ Cells Delivered to a Collagen Patch on Cryoinjured Rat Heart Promote Angiogenesis and Arteriogenesis 88
Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy 87
Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress 82
ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow 76
The regenerative potential of the amniotic fluid stem cells secretome 74
Small Extracellular Vesicles from Human Amniotic Fluid Samples as Promising Theranostics 67
Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia 65
Thymosin β4 protein therapy for cardiac repair. 65
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 64
Scientists on the Spot: Repairing and restoring the heart 60
Wide spread and systemic engraftment after in utero autologous transplantation of amniotic fluid mesenchymal stem cells into sheep fetuses 58
Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart 58
Stem cell therapy for myocardial ischemia: myth or reality? 54
Tackling the NAD-­related signaling pathways to counteract doxorubicin-induced cardiotoxicity 53
Investigating the Paracrine Role of Perinatal Derivatives: Human Amniotic Fluid Stem Cell-Extracellular Vesicles Show Promising Transient Potential for Cardiomyocyte Renewal 51
Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications 49
Widespread Engraftment after In Utero Autologous Transplantation of Amniotic Fluid Derived Mesenchymal Stem Cells into Sheep Fetuses. 47
Young at Heart: Combining Strategies to Rejuvenate Endogenous Mechanisms of Cardiac Repair 45
From novel discovery tools and biomarkers to precision medicine - basic cardiovascular science highlights of 2021/2022 44
Old, but gold? Not the case for the immune system when promoting systemic ageing 39
Editorial: Straight from the heart: Novel insights and future perspectives for cardiac repair 39
To serve and protect: a new heart patrolling and recycling role for macrophages 35
General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications 33
Editorial: Novel strategies to repair the infarcted heart, volume II 30
Scientists on the Spot: Rejuvenating the heart with RNA 29
The human amniotic fluid stem cell secretome triggers intracellular Ca2+ oscillations, NF-κB nuclear translocation and tube formation in human endothelial colony-forming cells 29
Guidelines to Analyze Preclinical Studies Using Perinatal Derivatives 24
Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy 23
Scientists on the Spot: Cardiovascular ageing and stroke 22
Tackling the NAD-related signaling pathways to counteract doxorubicin-induced cardiotoxicity 13
Tackling The NAD-Related Signaling Pathways To Counteract Doxorubicin-Induced Cardiotoxicity 13
Tackling the NAD-related signaling pathways to counteract doxorubicin-induced cardiotoxicity 13
Optimizing the human perinatal progenitor cell secretome for future paracrine therapy to counteract cardiac disease with AmnioSMART: an ERA4Health-funded project 9
Totale 6.883
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.829
article - articoli 24.714
book - libri 0
conference - conferenze 257
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 858
Totale 51.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021395 0 0 0 31 41 35 33 46 47 71 45 46
2021/2022685 17 37 37 58 40 50 38 173 61 68 28 78
2022/2023548 51 51 9 49 83 84 0 43 86 4 78 10
2023/2024423 20 60 9 58 35 52 35 38 14 3 31 68
2024/20251.346 77 84 32 75 192 170 109 209 52 77 129 140
2025/2026759 306 62 169 222 0 0 0 0 0 0 0 0
Totale 6.883